Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. junior Avg
|
New words:
activist, ahead, Alnylam, Alpine, Asian, beneficiary, bilirubin, BMS, burden, captured, cemdisiran, CODM, Disaggregation, diversification, donut, efgartigimod, Engelheim, Enjaymo, ethically, EZ, fifteen, forecast, fovea, fusion, Galimedix, Gazyva, generalizability, HHS, hole, ICU, indexed, lt, luminance, mandatorily, mandatory, mRNA, NeuroSense, nondeductible, Ocugen, oligonucleotide, ordinarily, outperformed, PE, pepinemab, POC, povetacicept, pozelimab, predominantly, pulled, Recordati, registry, repair, resubmission, scrutinizing, siRNA, spectrum, structural, subpopulation, sumscore, Vaccinex, vii, window
Removed:
Biden, biology, Carolina, constantly, constitutionality, Cooperation, copy, correlate, cylindrical, cytoplasm, degenerating, demyelinating, dismissed, dispensed, driver, emerged, excluding, Georgia, greatest, inactive, Indiana, instructed, intracellular, Jersey, marker, Maryland, multifocal, Nebraska, neuropathy, Pennsylvania, polyneuropathy, reconsider, reexamining, representing, ruling, sharing, subunit, sutimlimab, Treaty, unnecessary
Filing tables
Filing exhibits
Related press release
ANNX similar filings
Filing view
External links